BioCentury | Sep 12, 2019
Distillery Therapeutics
Inhibition of G9A and DNMT methyltransferases in bladder cancer
DISEASE CATEGORY: Cancer INDICATION: Bladder cancer Dual inhibition of G9A and DNMT methyltransferases, in combination with cisplatin and anti-programmed cell death 1 ligand 1 (PD-L1), could help to treat bladder cancer. A tool compound that...